BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Funko
FNKO
$339M
| $62.3K | ﹤0.01% |
3,632
+1,094
| +43% | +$17.9K |
|
|
TPCO
3402
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $62.2K | ﹤0.01% |
4,729
+1,938
| +69% | +$20.4K |
|
3403
Viking Therapeutics
VKTX
$3.89B
| $61.9K | ﹤0.01% |
7,719
-2,065
| -21% | -$15.1K |
|
3404
OrthoPediatrics
KIDS
$648M
| $61.4K | ﹤0.01% |
1,307
-33
| -2% | -$1.28K |
|
3405
CryoPort
CYRX
$766M
| $61.2K | ﹤0.01% |
3,717
-1,145
| -24% | -$17K |
|
3406
Hackett Group
HCKT
$272M
| $61.1K | ﹤0.01% |
3,787
-63
| -2% | -$1K |
|
3407
Assembly Biosciences
ASMB
$595M
| $61.1K | ﹤0.01% |
249
-39
| -14% | -$7.18K |
|
3408
Digimarc Corp
DMRC
$158M
| $60.9K | ﹤0.01% |
1,814
+13
| +0.7% | +$466 |
|
3409
Northrim BanCorp
NRIM
$604M
| $60.9K | ﹤0.01% |
6,356
+1,980
| +45% | +$18.9K |
|
3410
Construction Partners
ROAD
$6.76B
| $60.8K | ﹤0.01% |
3,605
+2,087
| +137% | +$36.6K |
|
|
STR
3411
DELISTED
Sitio Royalties
STR
| $60.5K | ﹤0.01% |
2,143
+924
| +76% | +$23.5K |
|
|
SRNE
3412
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $60.5K | ﹤0.01% |
17,889
-401
| -2% | -$956 |
|
3413
MacroGenics
MGNX
$263M
| $60.5K | ﹤0.01% |
5,557
-1,818
| -25% | -$18K |
|
|
RPT
3414
Rithm Property Trust
RPT
$100M
| $60.4K | ﹤0.01% |
704
+262
| +59% | +$23.3K |
|
|
MEET
3415
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $60.4K | ﹤0.01% |
12,055
+733
| +6% | +$3.45K |
|
|
CWBC
3416
Community West Bancshares
CWBC
$705M
| $60.4K | ﹤0.01% |
2,786
+919
| +49% | +$19.2K |
|
3417
Weis Markets
WMK
$1.78B
| $60.2K | ﹤0.01% |
1,488
-410
| -22% | -$15.9K |
|
3418
Q32 Bio
QTTB
$470M
| $60.2K | ﹤0.01% |
162
-41
| -20% | -$11.7K |
|
|
CMLS
3419
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $60K | ﹤0.01% |
3,416
+1,624
| +91% | +$24.9K |
|
|
CALA
3420
DELISTED
Calithera Biosciences, Inc
CALA
| $59.9K | ﹤0.01% |
525
+177
| +51% | +$13.3K |
|
3421
CALL
FMC
FMC
$1.25B
| $59.9K | ﹤0.01% |
6
| – | – |
|
|
3422
PUT
FMC
FMC
$1.25B
| $59.9K | ﹤0.01% |
6
| – | – |
|
3423
AMES National
ATLO
$283M
| $59.7K | ﹤0.01% |
2,129
+724
| +52% | +$20.1K |
|
|
PWOD
3424
DELISTED
Penns Woods Bancorp
PWOD
| $59.5K | ﹤0.01% |
1,673
+569
| +52% | +$18.1K |
|
3425
BioCryst Pharmaceuticals
BCRX
$2.5B
| $59.3K | ﹤0.01% |
17,179
-279
| -2% | -$702 |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.